| Literature DB >> 16612412 |
B Canaud1, M Morena, J P Cristol, D Krieter.
Abstract
beta(2)M is a strong and independent indicator of hemodialysis patient outcomes and an excellent surrogate for middle molecules, and deserves to be routinely monitored and incorporated into dialysis adequacy targets. beta(2)M has a double meaning, reflecting both dialysis efficacy in terms of solute mass transfer and patient bioactivity. The work of Ward et al. in this issue warrants a study to test the hypothesis that long daily hemodiafiltration treatment would be the optimal renal replacement modality to improve dialysis patient outcomes.Entities:
Mesh：
Substances：
Year: 2006 PMID： 16612412 DOI： 10.1038/sj.ki.5000389
Source DB: PubMed Journal: Kidney Int ISSN： 0085-2538 Impact factor: 10.612